Article
MTHFR polymorphism as a predictive biomarker for gastrointestinal and hematological toxicity in North Indian adenocarcinoma patients.
Journal of chemotherapy (Florence, Italy) - 1 Sept 2022
Walia Harleen Kaur, Singh Navneet, Sharma Siddharth
Abstract excerpt
In the present study, we investigated the relationship between the methylenetetrahydrofolate reductase (MTHFR) C677T and A1298C polymorphisms and overall survival, toxicity and treatment response for North Indian adenocarcinoma patients. The polymorphisms of MTHFR gene in north Indian adenocarcinoma patients were assessed by PCR-RFLP. Our data observed that patients with mutant genotype (C/C) for 1298 A>C)...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
